# Allergan Sales, LLC, Irvine, CA – FDA Inspections

Source: https://www.keypedia.com/companies/allergan-sales-llc/1c953156-6298-4351-8d2d-bc0fa979d4eb

> Inspection records and compliance data for Allergan Sales, LLC in Irvine, CA. 15 FDA inspections on record, 1 Form 483, last inspected November 07, 2025.

---

## Details

- Name: Allergan Sales, LLC
- FEI Number: 2011068
- Address Line 1: 2525 Dupont Dr.
- City: Irvine
- State: CA
- Zip Code: 92612
- Country Name: United States
- Address: 2525 Dupont Dr., Irvine, CA 92612, United States
- Country: United States

## Related Documents

- [483 - Allergan Sales, LLC - 2025-11-07](https://www.keypedia.com/records/483/allergan-sales-llc/22954531-e534-441b-863f-bbedcbf15b17) — source: FDA, date: November 7, 2025
- [FDA Inspection 1285134 - Allergan Sales, LLC - 2025-11-07](https://www.keypedia.com/records/fda_inspections/allergan-sales-llc/451dddd4-4210-4c54-869d-9da4fa3dc439) — source: FDA, date: November 7, 2025
- [FDA Inspection 1276207 - Allergan Sales, LLC - 2025-09-19](https://www.keypedia.com/records/fda_inspections/allergan-sales-llc/387c1e08-e915-46ee-a6bf-dd88f01012f8) — source: FDA, date: September 19, 2025
- FDA Inspection 1276207 - Allergan Sales, LLC - 2025-09-19 — classification: No Action Indicated (NAI), source: FDA, date: September 19, 2025
- FDA Inspection 1226167 - Allergan Sales, LLC - 2023-10-26 — source: FDA, date: October 26, 2023
- [FDA Inspection 1217963 - Allergan Sales, LLC - 2023-07-28](https://www.keypedia.com/records/fda_inspections/allergan-sales-llc/f8db6235-cab5-4ddf-b46d-a4932de3ec7f) — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2023
- [EIR - Allergan Sales, LLC - 2019-01-22](https://www.keypedia.com/records/eir/allergan-sales-llc/2d27d1f8-96e5-449e-99a5-31ae7ee72003) — source: FDA, date: January 22, 2019
- FDA Inspection 1077891 - Allergan Sales, LLC - 2019-01-22 — classification: No Action Indicated (NAI), source: FDA, date: January 22, 2019
- FDA Inspection 991910 - Allergan Sales, LLC - 2016-10-19 — classification: No Action Indicated (NAI), source: FDA, date: October 19, 2016
- [FDA Inspection 966871 - Allergan Sales, LLC - 2016-01-15](https://www.keypedia.com/records/fda_inspections/allergan-sales-llc/2f64dfbe-2bad-4efc-bff4-2ea08f4ca05f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 15, 2016
- FDA Inspection 951257 - Allergan Sales, LLC - 2015-12-07 — classification: No Action Indicated (NAI), source: FDA, date: December 7, 2015
- FDA Inspection 890000 - Allergan Sales, LLC - 2014-04-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2014
- [EIR - Allergan Sales, LLC - 2013-12-23](https://www.keypedia.com/records/eir/allergan-sales-llc/91c351ee-92b4-4c2e-b329-5213c4eced38) — source: FDA, date: December 23, 2013
- [483 - Allergan Sales, LLC - 2010-07-09](https://www.keypedia.com/records/483/allergan-sales-llc/dc2754a0-383b-4aca-b94a-0cc7b5d6a4cb) — source: FDA, date: July 9, 2010

## Related Companies

- [Mallinckrodt Pharmaceuticals Ireland Ltd](https://www.keypedia.com/companies/mallinckrodt-pharmaceuticals-ireland-ltd/f34c4783-1bab-4d23-a4e7-2db8ba642208)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [AbbVie Bioresearch Center](https://www.keypedia.com/companies/abbvie-bioresearch-center/6957449c-4de8-444b-b53c-5838b33a76a1)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)
- [Siegfried USA, LLC](https://www.keypedia.com/companies/siegfried-usa-llc/0e21650d-f620-4e29-a62d-aa4ecd79cef2)
- [Coating Place, Inc.](https://www.keypedia.com/companies/coating-place-inc/b7de7bca-85e6-4dfb-bcf2-61ccf93cba0e)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad)
- [Genzyme Flanders](https://www.keypedia.com/companies/genzyme-flanders/5f71d574-8097-4cd8-9254-2f8b85700e59)

## Related Officers

- [Investigator](https://www.keypedia.com/people/binh-t-nguyen/14ca5620-1f92-4f5d-8663-3b63814aca26)
- [issuing_officer](https://www.keypedia.com/people/diane-c-van-leeuwen/98af0d70-2db1-4132-8193-fcccf8841960)
- [company_representative](https://www.keypedia.com/people/rena-pandit/a5e1420b-5bdd-4601-8a6d-43cdf7083444)
- [company_representative](https://www.keypedia.com/people/naduka-k-amaratunge/10cad4b3-e0e2-48af-b427-ef20c49641dd)
- [company_representative](https://www.keypedia.com/people/elaina-hontalas/17b12acc-a80d-41c9-9792-1cee96189320)